Articles tagged with 'FDA' | BIOTRONIK

BIOTRONIK - Archive (FDA)

2022
26
July
2022
| 17:06 Europe/Amsterdam
BIOTRONIK announced that it received U.S. Food and Drug Administration (FDA) approval of its innovative Pulsar®-18 T3 peripheral self-expanding stent system for an improved implantation procedure for endovascular treatments. The company also announce...
Read more
2021
30
September
2021
| 10:35 Europe/Amsterdam
BIOTRONIK announced today it received U.S. Food and Drug Administration (FDA) approval of its Orsiro® Mission bioabsorbable polymer coronary drug-eluting stent system (BP-DES). The company also announced the first US implant and full commercial avail...
Read more